Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories. Together, they discuss recent news about virus activity and explore the value of collaboration in shaping innovative diagnostic strategies.
Mayo Clinic’s cardiac (CV) remote monitoring service uses the compact MoMe Kardia cardiac monitoring device that yields a continuous, 24/7 stream of a patient’s ECG and motion data, no matter their location. Any troubling or burgeoning events are observed virtually the moment they occur, allowing one of Mayo Clinic’s certified rhythm analysis technicians to intervene and facilitate care in near real time. And this is only the beginning; remote patient services are the way of the future, and the future is already here.
Mayo Clinic Laboratories offers a ceremide test to advise patients and their clinicians of the potential risk of heart attack. Using liquid chromatography-mass spectrometry technology, the test renders an algorithmic score after sorting through molecular compounds of ceramides of cardiovascular interest. Ceramide testing can be used alongside traditional blood tests to investigate risk factors of coronary artery disease.
This week's research roundup feature: Semaglutide in HFpEF across obesity class and by body weight reduction.
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, talks with Andrew Tofilon, director of marketing at Mayo Clinic Laboratories. They discuss integrated marketing strategies for the outreach laboratory.
Mayo Clinic Laboratories is committed to security and to protecting your information. As part of this commitment, we will implement an optional two-step login process for Mayo Clinic Laboratories applications called Multi-Factor Authentication (MFA). This process is like the two-step login process used by many other apps and provides an extra layer of security.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the uptick of COVID-19 cases and the strains of the virus that are currently circulating.
This week's research roundup feature: There is a need to develop safe and effective pharmacologic options for the treatment of celiac disease (CeD); however, consensus on the appropriate design and configuration of randomized controlled trials (RCTs) in this population is lacking.
Marketing is an essential discipline of any successful laboratory outreach program. While specific marketing goals and audiences will differ for every program, most of them will certainly involve driving awareness and growth. A strong partnership with the organization’s marketing team will allow the laboratory to capitalize on the organization’s brand, connect with customers, and generate business. For a busy laboratory, the first step in marketing is often knowing where to focus the team’s valuable resources. Here are some practical marketing strategies any outreach laboratory can apply.
Hurricane Lee will be impacting the New England area and northeastern Canada this weekend. We are monitoring and tracking the situation with our logistics partners to minimize challenges. Your organization will be contacted directly by the couriers if a route is modified or canceled due to the storm.
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Jeff Meeusen, Ph.D., assistant professor of laboratory medicine and pathology and clinical chemist in the Division of Clinical Core Laboratory Services for the Department of Laboratory Medicine and Pathology at Mayo Clinic, who discusses a forthcoming guidance document on lipid testing.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories at Mayo Clinic, to talk about leprosy and why it’s been in the news recently. Leprosy, also known as Hansen’s disease, is a rare infectious disease caused by the bacteria Mycobacterium leprae.
Outreach manager Jane Hermansen regards Mayo Clinic as the pinnacle of healthcare. Having spent her formative years in Minnesota, she was inspired by her uncle Roger to embark on a path as a laboratory scientist. Presently, she oversees the Mayo Clinic Laboratories outreach consulting and network programs. In addition, she spearheads the laboratory industry's only outreach conference, Leveraging the Laboratory.